RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic
University of Michigan Rogel Cancer Center
Novartis
Technical University of Munich